Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD

Summary

The changes in liver function, body mass index, controlled attenuation parameters, liver stiffness and HBV-DNA at different time points in each group before and after treatment were counted to explore the clinical efficacy of Ganshuang granules combined with tenofovir in the treatment of CHB complicated with NAFLD.

Timeline

Start

2020-01-05

Primary completion

2021-12-20

Completion

2021-12-21

Publications

• Su C, Yang Q. Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease. Front Pharmacol. 2022 Dec 14;13:1032789. doi: 10.3389/fphar.2022.1032789. eCollection 2022.

Drugs

Indications